We’re thrilled to announce a collaboration with our companions at Melanoma Analysis Alliance to carry a curated expertise to sufferers and caregivers impacted by melanoma. In america, melanoma is likely one of the most typical sorts of most cancers, and its prevalence has tripled in latest a long time. It’s estimated that 100,000 individuals will probably be recognized with invasive melanoma annually, and greater than 1.4 million individuals presently dwell with the situation.
MRA is the world’s largest nonprofit funder of melanoma analysis and has been a member of the Antidote accomplice community since 2017. By way of ongoing collaboration, we’ve got carried out vital enhancements to their web site’s Scientific Trial Navigator powered by Antidote Match. The platform enhancements embrace a consumer circulation tailor-made to particular person responses, expanded capabilities addressing questions on uncommon melanoma subtypes, inquiries about earlier and forthcoming remedies and therapies, and nuanced enter choices for people in earlier illness levels.
These developments underscore Antidote and MRA’s unwavering dedication to enhancing the scientific trial search expertise for sufferers and caregivers impacted by melanoma. By prioritizing user-centric design and performance, the Scientific Trial Navigator goals to make the method of discovering related scientific trials extra environment friendly and tailors the expertise to the precise wants of sufferers and their care companions. To expertise this course of, go to curemelanoma.org/clinicaltrials now.